Research *CME

January 31, 2022

Journal Club Discusses Vaccines, Part 2 (CME)

Join us for another Psound Bytes Journal Club episode discussing noteworthy publications in psoriatic disease. In this episode, we discuss recent research related to vaccination with Dr. Sandy Chat from Indiana University School of Medicine.

This program is supported by educational grants from AbbVie, Amgen, Janssen and UCB.

Publications

Wack S, Patton T, Ferris LK. COVID-19 vaccine safety and efficacy in patients with immune-mediated inflammatory disease: Review of available evidence. J Am Acad Dermatol. 2021;85(5):1274-1284. doi:10.1016/j.jaad.2021.07.054

Machado PM, Lawson-Tovey S, Strangfeld A, et al. Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry [published online ahead of print, 2021 Dec 31]. Ann Rheum Dis. 2021;annrheumdis-2021-221490. doi:10.1136/annrheumdis-2021-221490

Dhama K, Patel SK, Natesan S, et al. COVID-19 in the elderly people and advances in vaccination approaches. Hum Vaccin Immunother. 2020;16(12):2938-2943. doi:10.1080/21645515.2020.1842683

Uprety S, Paudel S, Thapa P. Pattern of Skin Diseases in Geriatric Population: Our Year-Long Experience from Nepal. Indian Dermatol Online J. 2021;12(6):888-891. Published 2021 Nov 22. doi:10.4103/idoj.IDOJ_65_21

Eyre DW, Taylor D, Purver M, et al. Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants [published online ahead of print, 2022 Jan 5]. N Engl J Med. 2022;NEJMoa2116597. doi:10.1056/NEJMoa2116597

Liu L, Iketani S, Guo Y, et al. Striking Antibody Evasion Manifested by the Omicron Variant of SARS-CoV-2 [published online ahead of print, 2021 Dec 23]. Nature. 2021;10.1038/s41586-021-04388-0. doi:10.1038/s41586-021-04388-0

Piccolo V, Russo T, Mazzatenta C, et al. COVID vaccine-induced pustular psoriasis in patients with previous plaque type psoriasis [published online ahead of print, 2022 Jan 11]. J Eur Acad Dermatol Venereol. 2022;10.1111/jdv.17918. doi:10.1111/jdv.17918

Huang YW, Tsai TF. Exacerbation of Psoriasis Following COVID-19 Vaccination: Report From a Single Center. Front Med (Lausanne). 2021;8:812010. Published 2021 Dec 23. doi:10.3389/fmed.2021.812010

Wei N, Kresch M, Elbogen E, Lebwohl M. New onset and exacerbation of psoriasis after COVID-19 vaccination. JAAD Case Rep. 2022;19:74-77. doi:10.1016/j.jdcr.2021.11.016

Demiri J, Abdo M, Tsianakas A. Erythroderme Psoriasis nach COVID-19-Erkrankung [Erythrodermic psoriasis after COVID-19] [published online ahead of print, 2021 Dec 14]. Hautarzt. 2021;1-4. doi:10.1007/s00105-021-04931-0

Agarwal A, Tripathy T, Kar BR. Guttate flare in a patient with chronic plaque psoriasis following COVID-19 infection: A case report. J Cosmet Dermatol. 2021;20(10):3064-3065. doi:10.1111/jocd.14396

Arbel R, Hammerman A, Sergienko R, et al. BNT162b2 Vaccine Booster and Mortality Due to Covid-19. N Engl J Med. 2021;385(26):2413-2420. doi:10.1056/NEJMoa2115624

Seror R, Camus M, Salmon JH, et al. Do JAK inhibitors affect immune response to COVID-19 vaccination? Data from the MAJIK-SFR Registry. Lancet Rheumatol. 2022;4(1):e8-e11. doi:10.1016/S2665-9913(21)00314-3

Mahil SK, Bechman K, Raharja A, et al. Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study. Lancet Rheumatol. 2022;4(1):e42-e52. doi:10.1016/S2665-9913(21)00333-7

Cristaudo A, Graceffa D, Pimpinelli F, et al. Immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in psoriasis patients treated with biologic drugs [published online ahead of print, 2021 Dec 11]. J Eur Acad Dermatol Venereol. 2021;10.1111/jdv.17861. doi:10.1111/jdv.17861

Share
Related Items

Stay in the Know.

Expert tips, can’t-miss events and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity Navigator

Copyright © 1996-2021 National Psoriasis Foundation/USA


Duplication, rebroadcast, republication or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.